These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19322471)

  • 41. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy.
    Kim J; Piao Y; Hyeon T
    Chem Soc Rev; 2009 Feb; 38(2):372-90. PubMed ID: 19169455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chiral switch: pure enantiomers of drugs instead of racemic mixtures].
    Valentová J; Hutt AJ
    Ceska Slov Farm; 2004 Nov; 53(6):285-93. PubMed ID: 15630994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Greener nanoscience: a proactive approach to advancing applications and reducing implications of nanotechnology.
    Hutchison JE
    ACS Nano; 2008 Mar; 2(3):395-402. PubMed ID: 19206562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs.
    Zolnik BS; Sadrieh N
    Adv Drug Deliv Rev; 2009 Jun; 61(6):422-7. PubMed ID: 19389437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chiral expression from molecular assemblies at metal surfaces: insights from surface science techniques.
    Raval R
    Chem Soc Rev; 2009 Mar; 38(3):707-21. PubMed ID: 19322464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of Chirality in Drugs: An Overview.
    Alkadi H; Jbeily R
    Infect Disord Drug Targets; 2018; 18(2):88-95. PubMed ID: 28356054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Advances in enantioselective TLC of therapeutic agents].
    Subert J; Slais K
    Ceska Slov Farm; 2005 Jul; 54(4):159-62. PubMed ID: 16124195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbial/enzymatic synthesis of chiral pharmaceutical intermediates.
    Patel RN
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):902-20. PubMed ID: 14758760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Approaching nanoscale oxides: models and theoretical methods.
    Bromley ST; Moreira Ide P; Neyman KM; Illas F
    Chem Soc Rev; 2009 Sep; 38(9):2657-70. PubMed ID: 19690745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Linear dislocation tunes chirality: STM study of chiral transition and amplification in a molecular assembly on an HOPG surface.
    Chen T; Chen Q; Pan GB; Wan LJ; Zhou QL; Zhang RB
    Chem Commun (Camb); 2009 May; (19):2649-51. PubMed ID: 19532909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent applications of chromatographic resolution of enantiomers in pharmaceutical analysis.
    Bojarski J; Aboul-Enein HY
    Biomed Chromatogr; 1996; 10(6):297-302. PubMed ID: 8949911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microfluidic systems for high-throughput and combinatorial chemistry.
    Cullen CJ; Wootton RC; de Mello AJ
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):798-806. PubMed ID: 15595440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enantioselective crystallization of histidine on chiral self-assembled films of cysteine.
    Dressler DH; Mastai Y
    J Colloid Interface Sci; 2007 Jun; 310(2):653-60. PubMed ID: 17412357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Artificial Chiral Probes and Bioapplications.
    Hao C; Xu L; Kuang H; Xu C
    Adv Mater; 2020 Oct; 32(41):e1802075. PubMed ID: 30656745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stereoselectivity in drug metabolism.
    Lu H
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):149-58. PubMed ID: 17428147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficient enantioselective separation of drug enantiomers by immobilised antibody fragments.
    Nevanen TK; Söderholm L; Kukkonen K; Suortti T; Teerinen T; Linder M; Söderlund H; Teeri TT
    J Chromatogr A; 2001 Aug; 925(1-2):89-97. PubMed ID: 11519820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Micro- and nanofluidic systems for high-throughput biological screening.
    Hong J; Edel JB; deMello AJ
    Drug Discov Today; 2009 Feb; 14(3-4):134-46. PubMed ID: 18983933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On-line racemization by high-performance liquid chromatography.
    Cannazza G; Carrozzo MM; Battisti U; Braghiroli D; Parenti C
    J Chromatogr A; 2009 Jul; 1216(30):5655-9. PubMed ID: 19539938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immobilized-type chiral packing materials for HPLC based on polysaccharide derivatives.
    Ikai T; Yamamoto C; Kamigaito M; Okamoto Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(1):2-11. PubMed ID: 18502192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.